WAY-639418

CAS No. 643042-43-7

WAY-639418( —— )

Catalog No. M37702 CAS No. 643042-43-7

WAY-639418 has potential anti-inflammatory and anti-HIV activity and can be used to study CCR5-mediated inflammatory and immunomodulatory diseases.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
2MG 62 Get Quote
5MG 92 Get Quote
10MG 147 Get Quote
25MG 241 Get Quote
50MG 358 Get Quote
100MG 516 Get Quote
500MG 1071 Get Quote
1G Get Quote Get Quote

Biological Information

  • Product Name
    WAY-639418
  • Note
    Research use only, not for human use.
  • Brief Description
    WAY-639418 has potential anti-inflammatory and anti-HIV activity and can be used to study CCR5-mediated inflammatory and immunomodulatory diseases.
  • Description
    WAY-639418 is an active molecule for the study of amyloid diseases and synucleinopathies.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Autophagy
  • Target
    CCR
  • Recptor
    CCR | HIV Protease
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    643042-43-7
  • Formula Weight
    325.8
  • Molecular Formula
    C17H16ClN5
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    ClC=1C=CC=2C(=NC=CC2N3CCN(C4=NC=CC=N4)CC3)C1
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

molnova catalog
related products
  • Manninotriose

    Manninotriose has the pharmacological activities, such as promoting the proliferation of hematopoietic cells, improving immunity, lowering blood glucose and anti-tumor.

  • Leronlimab

    Leronlimab (PRO 140) is a humanized IgG4 anti-CCR5 monoclonal antibody with both anti-HIV and anti-tumor activity, inhibiting CCR-mediated HIV-1 virus and cancer cell metastasis in mouse tumor models. Leronlimab can be used to study HIV, non-alcoholic steatohepatitis (NASH), and breast cancer.

  • CCR2 antagonist 5

    CCR2 antagonist 5 (JNJ-41443532) is a selective and orally active hCCR2 inhibitor with good binding affinity (IC50=37 nM) and potent functional antagonism (chemotaxis IC50=30 nM).